Insomnia is a classification of sleep disorders in which a person has trouble falling asleep, staying asleep or waking up too early. These disorders may also be defined by an overall poor quality of sleep. Insomnia is the most commonly reported sleep disorder. About 30 percent of adults have symptoms of insomnia. On average, most adults need seven to eight hours of sleep each night to feel alert and well-rested.
US National Sleep Foundation poll finds inadequate sleep is associated with health and safety. – One-third of Americans are losing sleep over the state of the U.S. economy and other personal financial concerns, according to a new poll released today by the National Sleep Foundation (NSF).
Anxious older adults sufferring from an anxiety disorders may benefit from antidepressants – Many older adults worry – a lot. Almost one in 10 Americans over age 60 suffer from an anxiety disorder that causes them to worry excessively about normal things – like health, finances, disability and family.
American Academy of Sleep Medicine Study Shows that the Societal, Economic Burden of Insomnia is High. – A study in the Jan. 1 issue of the journal Sleep indicates that the indirect costs of untreated insomnia are significantly greater than the direct costs associated with its treatment.
Clinical trial results on the sleep-promoting effects of Vanda Pharmaceuticals’ circadian regulator tasimelteon (VEC-162) published in the Lancet. – Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) reports publication in The Lancet, one of the world’s leading medical journals, results of clinical trials of its novel circadian regulator, experimental compound tasimelteon (VEC-162).
A unique longitudinal study is the first to analyze insomnia in adolescents both in association with mental health problems during adolescence and as a risk factor for mental health problems in young adulthood – Adolescent insomnia symptoms are associated with depression, suic_ide ideation and attempts, and the use of alcohol, cannabis and other drugs such as cocaine.
Acupuncture reduces side effects of breast cancer treatment as much as conventional drug therapy. Therapy shown to increase energy and overall well-being for breast cancer patients. – Acupuncture is as effective and longer-lasting in managing the common debilitating side effects of hot flashes, night sweats, and excessive sweating (vasomotor symptoms) associated with breast cancer treatment and has no treatment side effects compared to conventional drug therapy, according to a first-of-its-kind study presented September 24, 2008, at the American Society for Therapeutic Radiology and Oncology’s 50th Annual Meeting in Boston.
Xenazine (tetrabenazine) for the treatment of chorea i.e. jerky, involuntary movements in people with Huntington?s disease. – The U.S. Food and Drug Administration has approved Xenazine (tetrabenazine) for the treatment of chorea in people with Huntington’s disease. Chorea is the jerky, involuntary movement that occurs in people with this disease.
New Study in the Journal SLEEP Finds that a Short-Term Dose of Zolpidem is an Effective Treatment for Insomnia. – Zolpidem extended-release 12.5 mg, taken three to seven nights per week for up to six months, provided sustained and significant improvements in sleep onset and maintenance, and also improved next-day concentration and morning sleepiness in people with insomnia.
FDA is warning consumers not to use Swad brand sindoor because the product contains high levels of lead, leading to lead toxicity or lead poisoning.
– The U.S. Food and Drug Administration is warning consumers not to use 3.5 oz. packages of Swad brand sindoor, an orange or red powder used in some traditional South Asian Pacific ceremonies that is applied to the face or scalp, imported by Raja Foods LLC of Skokie, Illinois because the product contains high levels of lead. Although the product was not intended to be sold for food use, its labeling is confusing and implies that it may be used as food.
